HyClone covers cell culture, gene modulation and magnetic beads. GE Healthcare officials expect the acquisition will expand its life sciences business.
Terms of the deal were not disclosed. The transaction was first announced in January.
More Articles on GE Healthcare:
GE Healthcare Recalls Infant Resuscitation Systems
GE Healthcare Expands Technology Offerings
New Mississippi Program to Connect Rural Diabetics with Specialists via Telehealth
Next Up in Uncategorized
-
Norfolk, Va.-based Sentara Health and Aetna have expanded their partnership to provide Medicare Advantage and Medicaid members with access to…
-
The FDA has approved Fayuvi (rebisufligene etisparvovec-hopf), the first treatment for pediatric patients with mucopolysaccharidosis type IIIA, also known as…
-
Healthcare leaders continue to grapple with an expanding list of threats to the industry’s stability, from workforce shortages and reimbursement…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
